- Author:
Masoud FOROUTAN
1
;
Fatemeh GHAFFARIFAR
Author Information
- Publication Type:Review
- Keywords: Toxoplasma gondii; Calcium-dependent protein kinase; Vaccines; Immunization; Adjuvant
- MeSH: Animals; Apicomplexa; Cell Movement; Epitopes; Humans; Immunization; Life Cycle Stages; Male; Molecular Biology; Phosphotransferases; Protein Kinases; Toxoplasma; Vaccines; Zoonoses
- From:Clinical and Experimental Vaccine Research 2018;7(1):24-36
- CountryRepublic of Korea
- Language:English
- Abstract: Toxoplasma gondii belongs to the Apicomplexa phylum that caused a widespread zoonotic infection in wide range of intermediate hosts. Over one-third of the world's population are latently infected with T. gondii and carry it. The complex life cycle of T. gondii indicates the presence of a plurality of antigenic epitopes. During the recent years, continuous efforts of scientists have made precious advances to elucidate the different aspects of the cell and molecular biology of T. gondii. Despite of great progresses, the development of vaccine candidates for preventing of T. gondii infection in men and animals is still remains a challenge. The calcium-dependent protein kinases (CDPKs) belongs to the superfamily of kinases, which restricted to the apicomplexans, ciliates, and plants. It has been documented that they contribute several functions in the life cycle of T. gondii such as gliding motility, cell invasion, and egress as well as some other critical developmental processes. In current paper, we reviewed the recent progress concerning the development of CDPK-based vaccines against acute and chronic T. gondii.